The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks.
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...
FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.
Investors are applauding Arcturus' collaboration with CSL.
Regulatory News:
Upfront payment of $450 million due to uniQure by May 13, 2021
MEXICO CITY __ Mexico is reducing its COVID-19 alert level in about half of the country’s states amid a drop in infections and hospitalizations in many places, including the capital.
MELBOURNE, Australia — Australia’s second-largest city will begin its third lockdown due to a rapidly spreading COVID-19 cluster centered on hotel quarantine.